FindTrial
Sign In

Development and validation of risk prediction models of lymph node metastasis in patients with esophageal cancer

Development and validation of risk prediction models of lymph node metastasis in patients with esophageal cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030360
Enrollment
Unknown
Registered
2020-02-29
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

Gold Standard:Pathological diagnosis
Index test:risk&#32
prediction&#32
models&#32
of&#32
lymph&#32
node&#32
metastasis&#32
in&#32
patients&#32
with&#32
esophageal&#32
cancer

Sponsors

The Sixth Medical Center of Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients with surgically resectable thoracic esophageal cancer; 2. Aged 18 to 75 years.

Exclusion criteria

Exclusion criteria: Patients with accompanied other malignant tumors.

Design outcomes

Primary

MeasureTime frame
possible factors of lymph node metastasis;SEN, SPE, ACC, AUC of ROC;—

Countries

China

Contacts

Public ContactSong Weian

The Sixth Medical Center of Chinese PLA General Hospital

18600310961@126.com+86 18600310961

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026